Premium
Upstream Bio Inc (UPB)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.87 | 20.5305039788 | 18.85 | 23.79 | 18.44 | 162906 | 21.68753141 | CS |
| 4 | -4.93 | -17.8300180832 | 27.65 | 29.3 | 17.0885 | 218641 | 22.23627291 | CS |
| 12 | 1.22 | 5.67441860465 | 21.5 | 29.3 | 17.0885 | 315183 | 23.51597733 | CS |
| 26 | 1.22 | 5.67441860465 | 21.5 | 29.3 | 17.0885 | 315183 | 23.51597733 | CS |
| 52 | 1.22 | 5.67441860465 | 21.5 | 29.3 | 17.0885 | 315183 | 23.51597733 | CS |
| 156 | 1.22 | 5.67441860465 | 21.5 | 29.3 | 17.0885 | 315183 | 23.51597733 | CS |
| 260 | 1.22 | 5.67441860465 | 21.5 | 29.3 | 17.0885 | 315183 | 23.51597733 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
